EQUITY RESEARCH MEMO
TrueBlue Clinical Research
Generated 5/10/2026
Executive Summary
Conviction (model self-assessment)65/100
TrueBlue Clinical Research is a privately held clinical trial site based in Tampa, Florida, with over 100 years of cumulative research experience. Founded in 2006, the company specializes in multi-specialty Phase Ib–IV studies, serving sponsors and patients with high-quality, dependable, and inclusive clinical trial services. As a dedicated site, TrueBlue plays a critical role in the clinical development ecosystem, offering expertise across therapeutic areas and ensuring patient access to innovative treatments. With a focus on operational excellence and patient-centricity, the company is well-positioned to capture the growing demand for decentralized and site-based trials, particularly in the southeastern United States.
Upcoming Catalysts (preview)
- Q2 2026Award of new clinical trial contracts from pharmaceutical sponsors75% success
- Q4 2026Completion of a pivotal study with potential FDA filing50% success
- TBDExpansion of therapeutic capabilities or site capacity60% success
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)